WELLS FARGO & COMPANY/MN - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$204,654,992
-1.7%
2,009,179
-2.6%
0.06%
+5.3%
Q2 2023$208,182,364
+4.7%
2,063,050
-4.5%
0.06%0.0%
Q1 2023$198,785,550
+2.0%
2,160,711
+0.6%
0.06%
-1.7%
Q4 2022$194,858,968
+10.6%
2,147,916
-7.3%
0.06%
+1.8%
Q3 2022$176,129,000
-20.7%
2,317,185
-11.8%
0.06%
-17.4%
Q2 2022$222,189,000
-17.9%
2,628,520
-14.8%
0.07%0.0%
Q1 2022$270,712,000
-2.2%
3,085,044
-2.6%
0.07%0.0%
Q4 2021$276,934,000
-36.3%
3,166,044
-40.4%
0.07%
-28.1%
Q3 2021$434,688,000
-11.7%
5,315,329
-1.5%
0.10%
-11.1%
Q2 2021$492,316,000
-0.9%
5,395,833
-7.2%
0.11%
-3.6%
Q1 2021$496,851,000
-17.2%
5,812,499
-8.5%
0.11%
-22.2%
Q4 2020$599,896,000
+5.0%
6,352,803
-3.3%
0.14%
-8.9%
Q3 2020$571,571,000
-0.5%
6,572,802
-0.0%
0.16%
-5.4%
Q2 2020$574,229,000
+4.9%
6,574,638
-1.0%
0.17%
-11.6%
Q1 2020$547,574,000
-14.3%
6,641,281
-2.1%
0.19%
+9.9%
Q4 2019$639,063,000
+9.5%
6,785,604
+1.1%
0.17%
+4.2%
Q3 2019$583,438,000
-4.5%
6,713,904
+0.3%
0.16%
-5.7%
Q2 2019$611,146,000
-18.9%
6,693,086
-14.7%
0.18%
-21.9%
Q1 2019$753,202,000
+11.3%
7,844,433
-1.3%
0.22%
-0.4%
Q4 2018$676,851,000
+2.6%
7,945,350
+3.6%
0.22%
+20.3%
Q3 2018$659,929,000
+12.6%
7,667,798
-1.2%
0.19%
+7.5%
Q2 2018$586,019,000
-7.6%
7,757,730
-1.2%
0.17%
-7.4%
Q1 2018$634,195,000
-4.1%
7,852,367
-0.5%
0.19%
-1.6%
Q4 2017$661,189,000
-2.2%
7,889,938
+0.0%
0.19%
-8.6%
Q3 2017$675,954,000
+4.7%
7,888,556
+2.0%
0.21%
+1.0%
Q2 2017$645,467,000
-4.5%
7,732,922
-15.0%
0.21%
-5.9%
Q1 2017$675,917,000
+14.4%
9,100,801
+12.2%
0.22%
+5.3%
Q4 2016$590,915,000
-0.2%
8,112,500
+8.2%
0.21%
-4.1%
Q3 2016$591,981,000
-4.2%
7,497,230
+0.1%
0.22%
-8.8%
Q2 2016$618,013,000
+15.7%
7,490,171
+1.6%
0.24%
+12.2%
Q1 2016$533,925,000
-16.1%
7,370,569
-0.3%
0.21%
-15.1%
Q4 2015$636,236,000
-9.0%
7,394,650
-2.8%
0.25%
-14.3%
Q3 2015$699,122,000
-8.0%
7,605,758
-1.6%
0.29%0.0%
Q2 2015$759,763,000
-49.4%
7,725,882
-49.2%
0.29%
+0.3%
Q1 2015$1,500,164,000
+113.5%
15,212,940
+100.6%
0.29%
+6.2%
Q4 2014$702,549,000
+1.0%
7,582,140
+2.6%
0.28%
-5.5%
Q3 2014$695,462,000
+8.8%
7,388,433
+4.6%
0.29%
+10.2%
Q2 2014$639,441,000
+8.3%
7,062,612
+1.7%
0.26%
+5.2%
Q1 2014$590,337,000
+3.3%
6,943,583
-2.4%
0.25%
+1.2%
Q4 2013$571,642,000
+2.3%
7,111,851
-2.4%
0.25%
-6.8%
Q3 2013$558,999,000
+8.2%
7,287,265
-0.2%
0.27%
-0.4%
Q2 2013$516,477,0007,304,2810.27%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders